Janus Henderson Global Life Sciences Fund I2 HEUR

WKN A0NCDN | ISIN IE00B2B36G96 |  Fonds
Factsheet
04.04.25
39,56 EUR-5,72 % (-2,40)
Created with Highcharts 7.0.1Risiko VolatilitätPerformance11%11.25%11.5%11.75%12%12.25%12.5%12.75%13%13.25%13.5%13.75%14%14.25%14.5%14.75%15%15…15.25%-20%-15%-10%-5%0%5%10%

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 BE0170813936 KBC Equity Fund Medical Technologies Classic +5,60 % +11,17 % 0,29
2 LU2418149048 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse F-acc, USD +2,70 % +12,14 % 0,03
3 LU0358044559 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse Q-acc, USD +2,42 % +12,13 % 0,01
4 LU0085953304 UBS (Lux) Equity Fund - Sustainable Health Transformation (USD), Anteilsklasse P-acc, USD +1,60 % +12,13 % -0,06
5 LU2384387564 CPR Invest - MedTech - A HUF - Acc +0,26 % +15,01 % -0,14
231 IE00B2B36G96 Janus Henderson Global Life Sciences Fund I2 HEUR -10,21 % +14,27 % -0,88
449 IE00BF2ZTL15 Wellington Global Health Care Equity Fund CHF D AccU -17,96 % +15,09 % -1,34
450 LU1864482606 Candriam Equities L Oncology, N-H - Capitalisation -15,90 % +13,31 % -1,37
451 LU2425425506 Candriam Equities L Oncology, V - Capitalisation -14,63 % +12,22 % -1,39
452 LU1864482515 Candriam Equities L Oncology, I - Capitalisation -14,90 % +12,22 % -1,41
453 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -14,98 % +12,22 % -1,42